IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Aurobindo Pharma

NSE:AUROPHARMA · ISIN INE406A01037

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Aurobindo Pharma

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Aurobindo Pharma Ltd - 524804 - Intimation Of 39Th Annual General Meeting Of Aurobindo Pharma Limited.BSE · exchange filing · pdf
Source filing
General Updates - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Aurobindo Pharma LimitedNSE · conference call · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Board Meeting Intimation for Intimation Of Board Meeting.BSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Press Release - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Acquisition - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-AcquisitionBSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - ANVISA Approval For Curateq Biologics'' Biosimilars Manufacturing FacilityBSE · exchange filing · pdf
Source filing
General Updates - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Acquisition - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-AcquisitionBSE · exchange filing · pdf
Source filing
General Updates - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Completion Of Transfer Of Company'S Domestic Branded Generic Pharmaceutical Formulations Products Business To Auropharm Limited, A Wholly Owned Subsidiary Of The CompanyBSE · exchange filing · pdf
Source filing
Acquisition - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on AcquisitionBSE · exchange filing · pdf
Source filing
General Updates - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Auroactive Pharma Private Limited, A Wholly Owned Subsidiary Of The Company. BSE · exchange filing · pdf
Source filing
Acquisition - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Trading Window - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on AcquisitionBSE · exchange filing · pdf
Source filing
Press Release - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Disclosure under SEBI Takeover Regulations - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
General Updates - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
General Updates - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Pre-Approval Inspection (PAI) At Eugia Steriles Private Limited, A 100% Stepdown Subsidiary Of The CompanyBSE · exchange filing · pdf
Source filing
General Updates - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Classification Of US FDA Inspection At Unit-III Of Eugia Pharma Specialities Limited, Pashamylaram (Our Wholly Owned Subsidiary) As OAIBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Aurobindo Pharma LimitedNSE · exchange filing · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Aurobindo Pharma LimitedNSE · conference call · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Aurobindo Pharma LimitedNSE · conference call · pdf
Source filing
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing